McCormick & Company Earnings Calls
| Release date | Jun 25, 2026 |
| EPS estimate | $0.692 |
| EPS actual | $0.80 |
| EPS Surprise | 15.61% |
| Revenue estimate | 1.914B |
| Revenue actual | 1.937B |
| Revenue Surprise | 1.20% |
| Release date | Mar 31, 2026 |
| EPS estimate | $0.594 |
| EPS actual | $0.660 |
| EPS Surprise | 11.11% |
| Revenue estimate | 1.787B |
| Revenue actual | 1.874B |
| Revenue Surprise | 4.89% |
| Release date | Jan 22, 2026 |
| EPS estimate | $0.88 |
| EPS actual | $0.86 |
| EPS Surprise | -1.83% |
| Revenue estimate | 1.845B |
| Revenue actual | 1.85B |
| Revenue Surprise | 0.307% |
| Release date | Oct 07, 2025 |
| EPS estimate | $0.83 |
| EPS actual | $0.85 |
| EPS Surprise | 2.53% |
| Revenue estimate | 1.715B |
| Revenue actual | 1.725B |
| Revenue Surprise | 0.561% |
Last 4 Quarters for McCormick & Company
Below you can see how MKC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 07, 2025 |
| Price on release | $65.62 |
| EPS estimate | $0.83 |
| EPS actual | $0.85 |
| EPS surprise | 2.53% |
| Date | Price |
|---|---|
| Oct 01, 2025 | $67.76 |
| Oct 02, 2025 | $68.09 |
| Oct 03, 2025 | $68.91 |
| Oct 06, 2025 | $68.29 |
| Oct 07, 2025 | $65.62 |
| Oct 08, 2025 | $65.81 |
| Oct 09, 2025 | $66.11 |
| Oct 10, 2025 | $66.66 |
| Oct 13, 2025 | $65.36 |
| 4 days before | -3.16% |
| 4 days after | -0.396% |
| On release day | 0.290% |
| Change in period | -3.54% |
| Release date | Jan 22, 2026 |
| Price on release | $61.20 |
| EPS estimate | $0.88 |
| EPS actual | $0.86 |
| EPS surprise | -1.83% |
| Date | Price |
|---|---|
| Jan 15, 2026 | $68.70 |
| Jan 16, 2026 | $67.04 |
| Jan 20, 2026 | $67.83 |
| Jan 21, 2026 | $66.56 |
| Jan 22, 2026 | $61.20 |
| Jan 23, 2026 | $60.79 |
| Jan 26, 2026 | $60.97 |
| Jan 27, 2026 | $63.41 |
| Jan 28, 2026 | $61.86 |
| 4 days before | -10.92% |
| 4 days after | 1.08% |
| On release day | -0.670% |
| Change in period | -9.96% |
| Release date | Mar 31, 2026 |
| Price on release | $50.44 |
| EPS estimate | $0.594 |
| EPS actual | $0.660 |
| EPS surprise | 11.11% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $52.78 |
| Mar 26, 2026 | $51.58 |
| Mar 27, 2026 | $53.07 |
| Mar 30, 2026 | $53.72 |
| Mar 31, 2026 | $50.44 |
| Apr 01, 2026 | $48.38 |
| Apr 02, 2026 | $48.85 |
| Apr 06, 2026 | $50.80 |
| Apr 07, 2026 | $51.02 |
| 4 days before | -4.43% |
| 4 days after | 1.15% |
| On release day | -4.08% |
| Change in period | -3.33% |
| Release date | Jun 25, 2026 |
| Price on release | $48.35 |
| EPS estimate | $0.692 |
| EPS actual | $0.80 |
| EPS surprise | 15.61% |
| Date | Price |
|---|---|
| Jun 18, 2026 | $46.64 |
| Jun 22, 2026 | $45.73 |
| Jun 23, 2026 | $47.38 |
| Jun 24, 2026 | $47.60 |
| Jun 25, 2026 | $48.35 |
| Jun 26, 2026 | $51.05 |
| Jun 29, 2026 | $52.06 |
| Jun 30, 2026 | $50.42 |
| Jul 01, 2026 | $52.91 |
| 4 days before | 3.67% |
| 4 days after | 9.43% |
| On release day | 5.58% |
| Change in period | 13.44% |
McCormick & Company Earnings Call Transcript Summary of Q2 2026
McCormick reported a strong Q2 driven largely by the McCormick de Mexico acquisition (≈12ppt of the 14% constant-currency sales growth) and continued momentum in Flavor Solutions. Organic sales grew ~2%, with pricing the primary driver and Americas Consumer volumes pressured by heightened price sensitivity and shifting demand. Management expects sequential Consumer volume improvement in Q3 and volume growth in Q4 via targeted revenue-growth-management actions, expanded distribution, value-focused marketing, and innovation. Gross profit margin expanded 270 bps (140 bps of which came from a tariff refund); underlying gross margin expanded ~130 bps. Adjusted EPS was $0.80, up 16% year-over-year; H1 operating cash flow improved to $431 million. Leverage is ~2.9x and the company plans continued deleveraging and balanced capital allocation (growth investment, dividends, debt paydown). Integration planning for the Unilever Foods transaction is progressing; management reiterates confidence in previously announced synergy and accretion targets (mid–high single‑digit adjusted EPS accretion in first 12 months, mid–high teens by year three). Full‑year guidance highlights: gross margins expected to expand 100–120 bps vs. 2025, Q3 adjusted operating income growth expected in high single to low double digits y/y, and management will use most of the tariff refund to offset elevated inflationary costs tied to the Middle East conflict.
Sign In
Buy MKC